These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3797653)

  • 1. Fibroadenomas: histopathologic and MR imaging features.
    Stelling CB; Powell DE; Mattingly SS
    Radiology; 1987 Feb; 162(2):399-407. PubMed ID: 3797653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of the human female breast. Current status and pathologic correlations.
    Powell DE; Stelling CB
    Pathol Annu; 1988; 23 Pt 1():159-94. PubMed ID: 2838793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of phyllodes breast tumors from fibroadenomas on MRI.
    Wurdinger S; Herzog AB; Fischer DR; Marx C; Raabe G; Schneider A; Kaiser WA
    AJR Am J Roentgenol; 2005 Nov; 185(5):1317-21. PubMed ID: 16247156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroadenomas: MR imaging appearances with radiologic-histopathologic correlation.
    Hochman MG; Orel SG; Powell CM; Schnall MD; Reynolds CA; White LN
    Radiology; 1997 Jul; 204(1):123-9. PubMed ID: 9205233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phyllodes tumor of the breast: correlation between MR findings and histologic grade.
    Yabuuchi H; Soeda H; Matsuo Y; Okafuji T; Eguchi T; Sakai S; Kuroki S; Tokunaga E; Ohno S; Nishiyama K; Hatakenaka M; Honda H
    Radiology; 2006 Dec; 241(3):702-9. PubMed ID: 17032912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
    Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
    Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI of the breast--histopathologic correlation.
    Heywang SH; Bassermann R; Fenzl G; Nathrath W; Hahn D; Beck R; Krischke I; Eiermann W
    Eur J Radiol; 1987 Aug; 7(3):175-82. PubMed ID: 3653109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of thymic epithelial tumors.
    Kushihashi T; Fujisawa H; Munechika H
    Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lactating breast: contrast-enhanced MR imaging of normal tissue and cancer.
    Espinosa LA; Daniel BL; Vidarsson L; Zakhour M; Ikeda DM; Herfkens RJ
    Radiology; 2005 Nov; 237(2):429-36. PubMed ID: 16244250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can MR Imaging contribute in characterizing well-circumscribed breast carcinomas?
    Yoo JL; Woo OH; Kim YK; Cho KR; Yong HS; Seo BK; Kim A; Kang EY
    Radiographics; 2010 Oct; 30(6):1689-702. PubMed ID: 21071383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plain MR imaging of breast lesions: a study using 3 mm slice thickness].
    Kumagai H; Ito H; Hashimoto S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Jul; 53(7):801-5. PubMed ID: 8378140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex): breast imaging findings.
    Courcoutsakis NA; Chow CK; Shawker TH; Carney JA; Stratakis CA
    Radiology; 1997 Oct; 205(1):221-7. PubMed ID: 9314989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiologic and pathologic findings in breast tumors with high signal intensity on T2-weighted MR images.
    Santamaría G; Velasco M; Bargalló X; Caparrós X; Farrús B; Luis Fernández P
    Radiographics; 2010 Mar; 30(2):533-48. PubMed ID: 20228333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Subtraction and dynamic MR images of breast cancer].
    Murakami Y; Aoki M; Harada J
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Apr; 53(4):375-86. PubMed ID: 8493070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast and axillary tissue MR imaging: correlation of signal intensities and relaxation times with pathologic findings.
    Wiener JI; Chako AC; Merten CW; Gross S; Coffey EL; Stein HL
    Radiology; 1986 Aug; 160(2):299-305. PubMed ID: 3726104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast carcinomas with strong high-signal intensity on T2-weighted MR images: pathological characteristics and differential diagnosis.
    Yuen S; Uematsu T; Kasami M; Tanaka K; Kimura K; Sanuki J; Uchida Y; Furukawa H
    J Magn Reson Imaging; 2007 Mar; 25(3):502-10. PubMed ID: 17326093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MR characterization of breast pathology using inversion recovery sequence].
    Testa A; Patrizio G; Beomonte Zobel B; Masciocchi C; Gallucci M; Cardone G; Ciccozzi A; Ventura T; Passariello R
    Radiol Med; 1989 Oct; 78(4):329-34. PubMed ID: 2595025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prototype coil for magnetic resonance imaging of the female breast. Work in progress.
    Stelling CB; Wang PC; Lieber A; Mattingly SS; Griffen WO; Powell DE
    Radiology; 1985 Feb; 154(2):457-62. PubMed ID: 3966132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation.
    Orel SG; Schnall MD; LiVolsi VA; Troupin RH
    Radiology; 1994 Feb; 190(2):485-93. PubMed ID: 8284404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.